The 20 Best Triple-Negative Breast Cancer Doctors Near Me in Columbia, MD

Learn more at marylandoncology.com. Dr. Sastry is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 52 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia. Dr. Sastry is board certified in American Board Of Internal Medicine.

Andrew Mener, M.D. has experience treating a wide range of adult hematologic and oncologic disorders, with a particular interest in treating breast, lung, gastrointestinal and hematologic malignancies. He takes great pride in delivering personalized, compassionate care and strives to effectively explain complex treatment options to his patients. He strongly believes in the importance of treating each and every patient as an individual. Learn more at marylandoncology.com. Dr. Mener is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Severe Congenital Neutropenia. Dr. Mener is board certified in American Board Of Internal Medicine.

Edward Lee, M.D. was named one of Baltimore’s “Top Doc’s” by Baltimore Magazine in 2000 and 2002. After receiving additional training in Hematology and Medical Oncology at the University of Maryland in 1984, he remained on faculty until 1997. During his academic career, Dr. Lee was chairman of the training program for five years, started the Bone Marrow Transplant Program at the University of Maryland in 1993, and wrote 50 original articles on leukemia, lymphoma and related diseases. In 1997, Dr. Lee entered private practice as Chief of Hematology and Medical Oncology at Sinai Hospital. Practicing in Columbia since 2001, Dr. Lee treats patients with all forms of cancer, maintaining a particular interest in breast cancer, leukemia, and lymphomas. Learn more at marylandoncology.com. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Paget Disease of the Breast, Breast Cancer, and Primary Lymphoma of the Brain. Dr. Lee is board certified in American Board Of Internal Medicine.

As an active participant in the medical community, Mohit Narang, M.D. has served as a primary investigator and research assistant on many trials. During Dr. Narang’s fellowship, he was honored with the invitation to attend the Masterclass in Clinical Oncology at Montecatini, Italy by the European School of Oncology. He holds professional memberships with the American Society of Clinical Oncology, American Society of Hematology, as well as the European Society of Medical Oncology. Learn more at marylandoncology.com. Dr. Narang is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Agranulocytosis, Paget Disease of the Breast, Thrombocytopenia, and Bone Marrow Transplant. Dr. Narang is board certified in American Board Of Internal Medicine.

Najeff Waseem is a Hematologist and a Hematologist Oncology provider practicing medicine in Columbia, Maryland. He has been practicing medicine for over 10 years. Dr. Waseem is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Chronic Familial Neutropenia, Agranulocytosis, and Triple-Negative Breast Cancer. Dr. Waseem is board certified in American Board Of Internal Medicine.

Dr. Olutayo Sogunro is a breast surgeon at Johns Hopkins Hospital and Johns Hopkins Howard County Medical Center. Dr. Sogunro works closely with experts from medical oncology, radiation oncology, imaging and pathology to deliver comprehensive multidisciplinary breast cancer care to patients in a convenient community setting. Dr. Sogunro's clinical focus is breast surgical oncology and the comprehensive multidisciplinary care of the patient with breast cancer. Her interest in health literacy and education about breast cancer screening in average and high-risk populations in addition to successful survivorship plans. Dr. Sogunro’s interest also includes oncoplastic surgery. Dr. Sogunro is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her clinical expertise encompasses Giant Mammary Hamartoma, Breast Cancer, Breast Cancer in Men, Mastectomy, and Gastrectomy. Dr. Sogunro is board certified in American Osteopathic Board Of Surgery.

Sally Cheston is a Radiation Oncologist practicing medicine in Columbia, Maryland. Dr. Cheston is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Breast Cancer, Intraductal Papilloma, Triple-Negative Breast Cancer, and Prostate Cancer. Dr. Cheston is board certified in American Board Of Radiology.

Sarah Mcavoy is a Radiation Oncologist practicing medicine in Columbia, Maryland. Dr. Mcavoy is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Metastatic Brain Tumor. Dr. Mcavoy is board certified in American Board Of Radiology.

Dr. Santa-Maria completed his oncology training at Johns Hopkins, and has been focused on caring for patients with breast cancer since then. He works as both a primary oncologist and consultant for patients with all types and stages of breast cancer. His research interest is in developing new types of treatment for patients with breast cancer using immunotherapy. Dr. Santa is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Santa is board certified in American Board Of Internal Medicine.

Maryam Jaberi is a General Surgeon practicing medicine in Columbia, Maryland. Dr. Jaberi is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Subareolar Abscess, Hernia Surgery, and Small Bowel Resection.

Ari Elman is an Oncologist practicing medicine in Columbia, Maryland. He has been practicing medicine for over 17 years. Dr. Elman is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Multiple Myeloma.

Noeline Rajarajan is a General Surgeon practicing medicine in Columbia, Maryland. Dr. Rajarajan is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Breast Lump, and Intraductal Papilloma.

William Houck is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Houck is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 73 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Chronic B-Cell Leukemia (CBCL), and Richter Syndrome. Dr. Houck is board certified in American Board Of Internal Medicine.

Dr. Kristin Redmond specializes in the treatment of brain tumors and leads the spinal radiosurgery program. She received her undergraduate degree from Princeton University where she graduated magna cum laude with a focus in neuro-psychology. She attended medical school and obtained a Masters in Public Health in health systems management at Tulane University where she was elected to the Alpha Omega Alpha Honor Medical Society as well as the Gold Humanism in Medicine Honor Society. Dr. Redmonds research interest focuses on the development of novel radiation techniques and therapeutic agents to treat brain and spine tumors in order to increase tumor control and overall survival. In addition, she is working to develop innovative approaches to try to limit long term toxicities and minimize neuro-cognitive dysfunction following treatment for tumors of the central nervous system. Dr. Redmond believes in a holistic approach to medicine and feels that the social and psychological components of patient care are equally important to traditional therapies. She works closely with a team of specialists to support patients and families during their cancer journey. Make A Gift. Dr. Redmond is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Chordoma, Brain Tumor, Astrocytoma, and Metastatic Brain Tumor. Dr. Redmond is board certified in American Board Of Radiology.

Dr. Kleinberg specializes in the radiation treatments, including stereotactic radiosurgery, of brain and spinal tumors. Areas of research include both tumors arising in the central nervous system and tumors metastasizing from other locations. He also specializes in the treatment of esophageal tumors and has led national clinical trials in both therapy of brain tumors as well as esophageal cancer. Dr. Kleinberg has been recently named in the US News and World Report list of top 1% of doctors in his specialty. He is the co-chair of the Eastern Cooperative Oncology Group Brain Tumor Working Group, Vice-Chair of the NCI Cooperative Group Steering Committee for Esophageal and Gastric Tumors, and is a member of the NCI Cooperative Group Steering Committee for Gastrointestinal Tumors. He is also on the American College of Radiation Oncology Neurologic Cancer Practice Accreditation Team. Make A Gift. Dr. Kleinberg is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Brain Tumor, Hepato-Pancreato-Biliary Surgery, and Gamma Knife Radiosurgery. Dr. Kleinberg is board certified in American Board Of Radiology.

Stéphanie Gaillard is a medical oncologist who specializes in the treatment of gynecologic malignancies. She recently joined the faculty of the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and is their Director of Gynecologic Cancer Trials. Dr. Gaillard earned her medical degree and doctoral degree in cancer biology from Duke University. Following medical school, she underwent residency training in Internal Medicine and fellowship training in Medical Oncology at the Johns Hopkins School of Medicine. Dr. Gaillard’s research focuses on the development of clinical trials aimed at improving outcomes by incorporating promising new biologic, targeted, and immune therapies into standard treatment regimens. Her translational research program focuses on understanding the immune environment associated with gynecologic cancers and mechanisms of resistance to current therapies. Dr. Gaillard is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Tissue Biopsy, and Salpingo-Oophorectomy. Dr. Gaillard is board certified in American Board Of Internal Medicine.

Ming Yi is a primary care provider, practicing in Geriatrics in Catonsville, Maryland. Dr. Yi is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Renovascular Hypertension, Nephrosclerosis, Acute Pain, Hepato-Pancreato-Biliary Surgery, and Percutaneous Coronary Intervention (PCI).

Takeo Fujii is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Fujii is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and PIK3CA-Related Overgrowth Spectrum. Dr. Fujii is board certified in American Board Of Internal Medicine.

Ravin Garg is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Garg is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Paget Disease of the Breast, Breast Cancer, and Thrombotic Thrombocytopenic Purpura. Dr. Garg is board certified in American Board Of Internal Medicine.

Dr. Kenneth Pienta is the Donald S. Coffey Professor of Urology and a professor of oncology at the Johns Hopkins School of Medicine. He also holds an appointment in the department of pharmacology and molecular sciences. He is an internationally recognized leader in prostate cancer research and translational science. Dr. Pienta serves as the director of research for the Brady Urological Institute and co-leader of the Kimmel Cancer Center's Prostate Cancer Program. Dr. Pienta has a proven, peer-reviewed track record in organizing and administering a translational research program that successfully incorporates bench research, agent development and clinical application. He has international expertise in the development of novel chemotherapeutic programs for prostate cancer and has championed the concept that translational research is often best accomplished by multi-disciplinary teams of scientists and clinicians. Under his direction, the success of these endeavors led to the receipt of the first annual American Association for Cancer Research Team Science Award in 2007. Dr. Pienta received his B.A. in human biology from the Johns Hopkins University. He earned his M.D. from the Johns Hopkins School of Medicine. He completed his residency at the University of Chicago Hospitals and Clinics and performed a fellowship in oncology at The Johns Hopkins Hospital. Prior to joining Johns Hopkins, Dr. Pienta was the associate vice president for research, health sciences for the University of the Michigan from 2012 to 2013 and director of precision medicine for the Michigan Center for Translational Pathology from 2008 to 2013. He joined the Johns Hopkins faculty in 2013. Dr. Pienta's research interests include the ecology of cancer, tumor microenvironment, metastasis, biomarker development and novel therapeutic development. Dr. Pienta is a two-time American Cancer Society Clinical Research Professor Award recipient. He holds several patents, has authored more than 350 peer-reviewed articles and has been the principle investigator on numerous local and national clinical trials. Dr. Pienta is currently actively developing clinical trials and treating patients with newly diagnosed high risk and metastatic prostate cancer. Dr. Pienta is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bone Tumor, Familial Prostate Cancer, Prostatectomy, and Orchiectomy. Dr. Pienta is board certified in American Board Of Internal Medicine.